Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (361-370 of 401) with videos related to

Pageof 41
Sort By:
Circulation. Genomic and Precision Medicine|January 12, 2021
Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic DiseaseNicholas A Marston, Giorgio E M Melloni, Yared Gurmu, et al.
Circulation|November 1, 2017
International Expert Consensus on Switching Platelet P2Y<sub>12</sub> Receptor-Inhibiting TherapiesDominick J Angiolillo, Fabiana Rollini, Robert F Storey, et al.
JACC. Cardiovascular Interventions|March 9, 2016
Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ AnalysisGilles Montalescot, Arnoud W van 't Hof, Leonardo Bolognese, et al.
JACC. Cardiovascular Interventions|December 6, 2024
Left Anterior Descending Nonculprit Lesions and Clinical Outcomes in Patients With ST-Segment Elevation Myocardial InfarctionBrian P McGrath, Natalia Pinilla-Echeverri, David A Wood, et al.
Circulation Research|December 10, 2015
Association of MicroRNAs and YRNAs With Platelet FunctionDorothee Kaudewitz, Philipp Skroblin, Lukas H Bender, et al.
Cardiovascular Drugs and Therapy|July 6, 2020
Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel PharmacogenomicsJoel A Morales-Rosado, Kashish Goel, Lingxin Zhang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 2, 2022
Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trialMasafumi Ono, Yoshinobu Onuma, Hideyuki Kawashima, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 15, 2020
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesionsMarco Zimarino, Dominick J Angiolillo, George Dangas, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 21, 2019
Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54Mikael Dellborg, Marc P Bonaca, Robert F Storey, et al.
The New England Journal of Medicine|March 17, 2015
Long-term use of ticagrelor in patients with prior myocardial infarctionMarc P Bonaca, Deepak L Bhatt, Marc Cohen, et al.
Pageof 41

Showing results (361-370 of 401) with videos related to

Sort By:
Pageof 41
Circulation. Genomic and Precision Medicine|January 12, 2021
Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic DiseaseNicholas A Marston, Giorgio E M Melloni, Yared Gurmu, et al.
Circulation|November 1, 2017
International Expert Consensus on Switching Platelet P2Y<sub>12</sub> Receptor-Inhibiting TherapiesDominick J Angiolillo, Fabiana Rollini, Robert F Storey, et al.
JACC. Cardiovascular Interventions|March 9, 2016
Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ AnalysisGilles Montalescot, Arnoud W van 't Hof, Leonardo Bolognese, et al.
JACC. Cardiovascular Interventions|December 6, 2024
Left Anterior Descending Nonculprit Lesions and Clinical Outcomes in Patients With ST-Segment Elevation Myocardial InfarctionBrian P McGrath, Natalia Pinilla-Echeverri, David A Wood, et al.
Circulation Research|December 10, 2015
Association of MicroRNAs and YRNAs With Platelet FunctionDorothee Kaudewitz, Philipp Skroblin, Lukas H Bender, et al.
Cardiovascular Drugs and Therapy|July 6, 2020
Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel PharmacogenomicsJoel A Morales-Rosado, Kashish Goel, Lingxin Zhang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 2, 2022
Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trialMasafumi Ono, Yoshinobu Onuma, Hideyuki Kawashima, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 15, 2020
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesionsMarco Zimarino, Dominick J Angiolillo, George Dangas, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 21, 2019
Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54Mikael Dellborg, Marc P Bonaca, Robert F Storey, et al.
The New England Journal of Medicine|March 17, 2015
Long-term use of ticagrelor in patients with prior myocardial infarctionMarc P Bonaca, Deepak L Bhatt, Marc Cohen, et al.
Pageof 41